3 vials 8% off · 5 vials 12% · 10 vials 18%

Quality system

Testing & certificates

These are image copies of third-party certificates for the described samples, not an authenticated original-report or current-inventory register. Results apply only to the sample tested; a matching compound name does not establish that your vial is from that batch. Research use only — not for human or animal use. An RUO label does not establish regulatory legality. Request the exact batch report by ticket if it is not shown here.

Published register
8 certificate images are shown with the identifiers and measurements transcribed from those images. Some identifiers are only cap-color descriptions.

Exact-lot scope
A report does not establish that a tested sample represents all vials or current stock. Match the exact vial batch with support before relying on a report.

Request timing
Requests are reviewed by support; response timing varies and no turnaround time is guaranteed.

This register does not provide authenticated original PDFs, raw chromatograms or peak tables, a verified chain of custody, method revisions, or test-specific accreditation scope. Storage, retest, and expiry information is not established here. HPLC purity or LC-MS identity results do not demonstrate sterility, safety, clinical suitability, or lawful use. Request source documentation and exact-batch confirmation before relying on a certificate.

Read testing documentation in context

These guides explain how to interpret HPLC reporting and evaluate research-material documentation. They do not establish that a listed report matches current inventory.

retatrutide 10mg

Freedom Diagnostics · reported lot RT10072726 · 99.59% · 10.02 mg

Report date: 2026-07-31 · Method shown: HPLC-UV / LC-MS · Original report PDF and revision: not available in this register. Confirm that the identifier matches your exact vial batch.

retatrutide 10mg certificate of analysis

retatrutide 20mg

Vanguard Laboratory · sample description Lime Green Cap · >99.80% ± 0.18% · 20.12 mg

Report date: 2026-02-26 · Method shown: HPLC-UV/VIS · Original report PDF and revision: not available in this register. The cap-color description is not a unique, independently traceable lot ID.

retatrutide 20mg certificate of analysis

retatrutide 30mg

Vanguard Laboratory · reported lot RT3042126 · >99.80% ± 0.18% · 29.84 mg

Report date: 2026-05-11 · Method shown: HPLC-UV/VIS · Original report PDF and revision: not available in this register. Confirm that the identifier matches your exact vial batch.

retatrutide 30mg certificate of analysis

bpc 157 10mg

Vanguard Laboratory · reported lot BC10051926 · >99.80% ± 0.18% · 11.21 mg

Report date: 2026-06-01 · Method shown: HPLC-UV/VIS · Original report PDF and revision: not available in this register. Confirm that the identifier matches your exact vial batch.

bpc-157 10mg certificate of analysis

tb 500 10mg

Freedom Diagnostics · reported lot 3457 · 99.35% · 10.11 mg

Report date: 2026-07-31 · Method shown: HPLC-UV / LC-MS · Original report PDF and revision: not available in this register. Confirm that the identifier matches your exact vial batch.

tb-500 10mg certificate of analysis

bpc tb blend 10mg/10mg

Vanguard Laboratory · sample description Orange Cap · >99.80% ± 0.18% · BPC-157 11.26 mg · TB-500 12.10 mg

Report date: 2026-02-26 · Method shown: HPLC-UV/VIS · Original report PDF and revision: not available in this register. The cap-color description is not a unique, independently traceable lot ID.

Quantity discrepancy under review: the image labels this blend as 20 mg, while its table lists BPC-157 at 11.26 mg and TB-500 at 12.10 mg. The relationship between those values and the advertised 10 mg/10 mg designation has not been verified. Do not use this image alone to validate the catalog quantity; request the original report and exact-batch confirmation.

bpc-tb-blend 10mg/10mg certificate of analysis

tesamorelin 10mg

Freedom Diagnostics · reported lot 9953797 · 99.56% · 10.04 mg

Report date: 2026-07-31 · Method shown: HPLC-UV / LC-MS · Original report PDF and revision: not available in this register. Confirm that the identifier matches your exact vial batch.

tesamorelin 10mg certificate of analysis

ghk cu 100mg

Vanguard Laboratory · reported lot GHK42126 · >99.80% ± 0.18% · 98.27 mg

Report date: 2026-05-08 · Method shown: HPLC-UV/VIS · Original report PDF and revision: not available in this register. Confirm that the identifier matches your exact vial batch.

ghk-cu 100mg certificate of analysis

Synthesis & lyophilization

The images below describe tested samples. Verify the batch identifier on your vial against the exact report; a cap-color description alone is not a unique batch ID.

HPLC purity

Published third-party reports show lot-specific HPLC results. Read the exact value for the listed compound and quantity; request unpublished lot files below.

Identity by LC-MS

Some published reports include LC-MS identity data for the tested sample. Results apply only to that sample and lot.

Dispatch

Outer cartons are plain. A packing list travels with the shipment. Use the request form when the exact lot certificate is not listed.

Request a certificate

Tell us the compound and, if you have it, the batch ID from the vial. We reply to the lab email if an exact lot file can be located. Product-page selections are carried into this form so you can request the exact catalog quantity without retyping it. Research use only — this is not a medical record.

Or email Vitalitysupply@icloud.com with subject “COA request”. Include the product name, catalog quantity, and batch ID if available. Do not send sensitive personal or payment data.

Shop documented compounds